Immunotherapies are amazing drugs against cancer. However, they still fail for too many patients. This video series presents IMPRES and TIDE, two of the best predictors of cancer immunotherapy outcomes. It also shows an easy way to combine them and improve their predictions. Finally, it makes suggestions of practical ways to contribute to research on this topic.